Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases.
Pauline TétuLila Sirven-VillarosStefania CuzzubboRenata UrsuBarouyr BaroudjianJulie DelyonFrançois NatafConstance De Margerie-MellonClara AllayousWendy LefevreAntoine F CarpentierCéleste LebbéPublished in: Cancers (2020)
Targeted therapy and immunotherapy are promising new treatment options in LM from melanoma that can increase overall survival, and may induce long lasting remission in some patients.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- early stage
- prognostic factors
- peritoneal dialysis
- radiation induced
- rheumatoid arthritis
- small cell lung cancer
- skin cancer
- squamous cell carcinoma
- patient reported outcomes
- systemic lupus erythematosus
- disease activity
- ulcerative colitis
- patient reported